| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/23/2012 | CA2808361A1 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder |
| 02/23/2012 | CA2808211A1 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases |
| 02/23/2012 | CA2807243A1 Combination therapy of an afucosylated cd20 antibody with an anti-vegf antibody |
| 02/23/2012 | CA2807227A1 Improved antibodies of the class igg4 |
| 02/23/2012 | CA2807222A1 Combination anti - cancer therapy |
| 02/23/2012 | CA2807218A1 Novel combination therapy for the treatment of cancer |
| 02/23/2012 | CA2806637A1 Antibodies for epidermal growth factor receptor 3 (her3) |
| 02/23/2012 | CA2805176A1 Humanized anti-interleukin 3 receptor alpha chain antibodies |
| 02/22/2012 | EP2420833A1 T-cell vaccine |
| 02/22/2012 | EP2420572A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof |
| 02/22/2012 | EP2420516A1 Rapid generation of T cell-independent antibody responses to T cell-dependent antigens |
| 02/22/2012 | EP2420515A1 Diagnosis and treatment of cancer using anti-tmprss11e antibody |
| 02/22/2012 | EP2420514A1 Targeted binding agents directed to PDGFR-alpha and uses thereof |
| 02/22/2012 | EP2420513A1 Targeted binding agents directed to PDGFR-alpha and uses thereof |
| 02/22/2012 | EP2420252A1 EPHB3-specific antibody and uses thereof |
| 02/22/2012 | EP2420251A2 Ligands that enhance endogenous compounds |
| 02/22/2012 | EP2420250A1 Anti-Syndecan-4 antibodies |
| 02/22/2012 | EP2420249A1 Vaccine immunotherapy for immune suppressed patients |
| 02/22/2012 | EP2420248A1 Mutated HIV NEF for modulating immunity |
| 02/22/2012 | EP2420247A1 Adenovirus formulations |
| 02/22/2012 | EP2420246A1 Methods and compositions based on shiga toxin type 1 protein |
| 02/22/2012 | EP2419451A1 Antibodies against prostate specific membrane antigen |
| 02/22/2012 | EP2419449A1 B-lymphocyte targeting agents for use in a method for the treatment of a disease |
| 02/22/2012 | EP2419447A1 Antibodies that specifically bind to a beta oligomers and use thereof |
| 02/22/2012 | EP2419137A1 Compositions and methods to treat acute myelogenous leukemia |
| 02/22/2012 | EP2419136A2 Compositions and methods for treating cancer |
| 02/22/2012 | EP2419135A1 Combination therapy using an anti-egfr agent(s) and igf-1r specific inhibitors |
| 02/22/2012 | EP2419134A1 Treatment of inflammatory diseases by inhibiting cold- inducible rna-binding protein (cirp) |
| 02/22/2012 | EP2419133A1 Rspondin-3 inhibition in bone disorders |
| 02/22/2012 | EP2419132A1 Recombinant avian herpes virus vectors and vaccine for immunizing waterfowl species |
| 02/22/2012 | EP2419131A1 Macrocyclic lactone combination compositions, vaccines and methods for producing same |
| 02/22/2012 | EP2419130A1 Meningococcal and pneumococcal conjugate vaccine and method of using same |
| 02/22/2012 | EP2419129A2 Compositions for immunising against staphylococcus aerus |
| 02/22/2012 | EP2419128A1 Engineered botulinum neurotoxin |
| 02/22/2012 | EP2419127A2 Gamma-glutamyl transpeptidase attenuated francisella |
| 02/22/2012 | EP2419126A1 Combination immunotherapy compositions against cancer and methods |
| 02/22/2012 | EP2419125A1 Use of vectors expressing intracellular polynucleotide binding proteins as adjuvants |
| 02/22/2012 | EP2419124A2 Foot-and mouth disease marker vaccine |
| 02/22/2012 | EP2419103A1 Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability |
| 02/22/2012 | EP2419010A1 Targeted detection of dysplasia in barrett's esophagus with a novel fluorescence-labeled polypeptide |
| 02/22/2012 | EP2361988A9 Molecular marker for cancer stem cell |
| 02/22/2012 | EP1805510B1 Therapeutic strategy for treating autoimmune and degenerative diseases |
| 02/22/2012 | EP1708752B1 Polymer-bound antibody cancer therapeutic agent |
| 02/22/2012 | EP1691836B1 Anti-pecam therapy for metastasis suppression |
| 02/22/2012 | EP1633387B1 Combinations of tumor-associated antigens for the treatment of various types of cancers |
| 02/22/2012 | EP1608767B1 Optimized expression of hpv 31 l1 in yeast |
| 02/22/2012 | EP1575531B9 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 02/22/2012 | EP1572234B1 STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES |
| 02/22/2012 | EP0979080B9 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/22/2012 | CN1980695B 抗原递送载体和构建物 Antigen delivery vectors and constructs |
| 02/22/2012 | CN1913921B 通过靶定暴露在细胞凋亡肿瘤细胞上的内部抗原杀死肿瘤细胞的方法 By targeting the apoptotic expose internal antigens of tumor cells to kill tumor cells of the |
| 02/22/2012 | CN1819844B 免疫原粘附抑制剂及其制备和使用方法 Immunogen adhesion inhibitors and their preparation and use |
| 02/22/2012 | CN1688702B 表达rna病毒抗原表位的重组麻疹病毒在制备疫苗组合物中的用途 Expression rna viral epitopes in the preparation of a recombinant measles virus vaccine composition of use |
| 02/22/2012 | CN102361981A Synthetic RNA-based agonists of TLR7 |
| 02/22/2012 | CN102361883A Bispecific anti-erbb-1/anti-c-met antibodies |
| 02/22/2012 | CN102361649A Influenza hemagglutinin and neuraminidase variants |
| 02/22/2012 | CN102361648A Salmonella marker vaccine |
| 02/22/2012 | CN102361646A Compounds and methods for modulating immune response |
| 02/22/2012 | CN102360015A Anti-alzheimer's disease monoclonal antibody and application thereof |
| 02/22/2012 | CN102358903A Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
| 02/22/2012 | CN102358751A Human fibrinogen-like protein 2 prothrombinase immunogenicity peptide and use thereof |
| 02/22/2012 | CN102357246A EGFR and HER2 combined polypeptide epitope vaccine |
| 02/22/2012 | CN102357062A Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 02/22/2012 | CN101906395B 一种口服免疫阻断鸡肌抑素作用的转化子及其应用 An oral immunization of chicken myostatin blocking effect of transformation and its application |
| 02/22/2012 | CN101780274B 猪链球菌病、多杀性巴氏杆菌病灭活疫苗及其制备方法 Streptococcus suis, Pasteurella multocida disease vaccine and its preparation method |
| 02/22/2012 | CN101683354B 一种肝损伤相关的药物靶点及其应用 One kind of liver injury associated with drug targets and its application |
| 02/22/2012 | CN101384279B 抗淀粉样蛋白免疫原性组合物、方法和用途 Anti-amyloid immunogenic compositions, methods and uses |
| 02/22/2012 | CN101362802B Dna依赖蛋白激酶催化亚基单链抗体及其编码基因与应用 Dna-dependent protein kinase catalytic subunit of single-chain antibody and its coding gene and application |
| 02/22/2012 | CN101300027B 分泌性IgA和IgG抗体诱导剂 Secretory IgA and IgG antibody-inducing agent |
| 02/22/2012 | CN101203241B 人源化抗-cd70结合物和其应用 Humanized anti -cd70 conjugates and their application |
| 02/22/2012 | CN101027084B 用于调节免疫的突变型hiv nef Mutant hiv nef for regulating immunity |
| 02/21/2012 | US8119787 Molecular tools for manufacturing anti-CD33 antibodies and fragments |
| 02/21/2012 | US8119767 Post-translational modifications and clostridial neurotoxins |
| 02/21/2012 | US8119395 Vaccines, immunotherapeutics and methods for using the same |
| 02/21/2012 | US8119340 Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia |
| 02/21/2012 | US8119337 Decreasing potential iatrogenic risks associated with influenza vaccines |
| 02/21/2012 | US8119147 Compositions produced using enteric pathogens and methods of use |
| 02/21/2012 | US8119146 Expressing hepatitis B virus surface antigen for vaccine preparation |
| 02/21/2012 | US8119145 Methods for producing norovirus VLPS |
| 02/21/2012 | US8119144 nucleotide sequences encoding HIV-1 Clade A Gag, Pol (RT and Int), and Nef ("GRIN), HIV-1 Clade A Gag, RT and Nef ("GRN") or HIV-1 Clade A Env; generating an immune response against HIV-1 |
| 02/21/2012 | US8119143 Multivalent PCV2 immunogenic compositions and methods of producing such compositions |
| 02/21/2012 | US8119140 Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins |
| 02/21/2012 | US8119139 Immunotherapy against several tumors including neuronal and brain tumors |
| 02/21/2012 | US8119138 Anti-estrogen and immune modulator combinations for treating breast cancer |
| 02/21/2012 | US8119137 Prevention of thrombus formation and/or stabilization with inhibitors of factor XII or activated factor XII |
| 02/21/2012 | US8119136 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 02/21/2012 | US8119135 Antibodies which bind to epitopes of glycoprotein VI |
| 02/21/2012 | US8119134 Method for extending pregnancy in patients exhibiting at least one symptom of preeclampsia and eclampsia |
| 02/21/2012 | US8119133 Engineered anti-IL-23R antibodies |
| 02/21/2012 | US8119132 Humanized anti-tag-72 monoclonal antibodies |
| 02/21/2012 | US8119131 IL-17 antagonistic antibodies |
| 02/21/2012 | US8119130 Targeted binding agents directed to KDR and uses thereof—035 |
| 02/21/2012 | US8119129 Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases |
| 02/21/2012 | US8119128 Antibodies that bind urokinase-type plasminogen activator and epitopes therefor |
| 02/21/2012 | US8119127 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 02/21/2012 | US8119126 anti-solid cancer agent; CXCR4 (chemokine) inhibitor; tissue-repairing agent comprising a CXCR4 potentiator |
| 02/21/2012 | US8119119 Retroviral vector for improving exogenous gene transfer and expression in cells |
| 02/21/2012 | US8119118 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 02/21/2012 | US8119114 Polymer conjugates of mutated neublastin |
| 02/21/2012 | US8119104 Treatment of celiac disease with IgA |